ClinConnect ClinConnect Logo
Search / Trial NCT05026645

The Medical Management in Patients Exposed to Weapons of Mass Destruction

Launched by ST. JUSTINE'S HOSPITAL · Aug 23, 2021

Trial Information

Current as of July 25, 2025

Enrolling by invitation

Keywords

Cbrne Defence Acute Settings Pre Hospital Settings Decontamination Protection Respiratory Insults Treatments

ClinConnect Summary

This is an ongoing multicentric observational study that aims to assess the medical response to chemical, biological, radiological, nuclear, explosive (cbrne) events during the last five (5) decades (i.e.: 1970-2020), and in any future cbrne attack that might occur within the next 15 years (i.e.: 2021-2036). Of note, the data collection will be performed retrospectively and after sites review ethic board (REB) approval.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • i. a CBRNE attack caused at least one casualty who required the assistance of the participating health care system (e.g.: physicians, nurses, paramedics and other health-care specialists of a medical facility) during a medical extraction from the incident site until admission to a medical facility;
  • ii. Patients are eligible if they were exposed to the CBRNE attack;
  • iii. Medical information concerning the CBRNE exposures, even if partial, is accessible to health care professionals for the purposes of filling out the online case report form (eCRF);
  • iv. Participants must be able to complete the online case report form in English; and
  • v. The approval of an Ethics Review Board is obtained by each medical centre participant.
  • Exclusion Criteria:
  • A negative response to any of the inclusion criteria results in an exclusion.

About St. Justine's Hospital

St. Justine's Hospital is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research. Renowned for its commitment to excellence in patient care and medical education, the hospital serves as a vital center for clinical trials aimed at improving therapeutic options for children. With a multidisciplinary team of experts, St. Justine's Hospital leverages cutting-edge technology and evidence-based practices to facilitate groundbreaking studies that address a wide range of pediatric conditions, ensuring the highest standards of safety and efficacy for its young patients.

Locations

Quebec, , Canada

Winnipeg, Manitoba, Canada

Ottawa, Ontario, Canada

Montreal, Quebec, Canada

Quebec, , Canada

Paris, Ile De France, France

Tokyo, Shinjuku Ku, Japan

Winnipeg, Manitoba, Canada

Winnipeg, Manitoba, Canada

Montreal, Quebec, Canada

Montreal, Quebec, Canada

Sherbrooke, Quebec, Canada

Quebec, , Canada

Tokyo, , Japan

Tokyo, , Japan

College Park, Maryland, United States

Tokyo, , Japan

Tokyo, , Japan

Montréal, Quebec, Canada

Prague, , Czechia

Surrey Quays, Redhill, United Kingdom

Winchester, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Stephane Bourassa

Principal Investigator

Ste-Justine's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials